2018 annual financial data
Avalo Therapeutics 2018 Financial results
Direct answer
Revenue was 18,326,801 USD.
Operating income was -39,313,766 USD and net income was -40,052,810 USD.
Operating cash flow was -3,128,102 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,326,801 USD
- Operating income
- -39,313,766 USD
- Net income
- -40,052,810 USD
- Operating cash flow
- -3,128,102 USD
Explore related company data
View all 2018 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Avalo Therapeutics financial years